At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 70 enrolled
Drug / intervention
Antibioticsdrug
Likely dose
Antibiotics 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Pilot and Feasibility Study of a cultuRE-Directed Approach to Urinary traCT Infection Symptoms in Older womeN: a Mixed Methods Evaluation - the REDUCTION Trial
In Brief
A Phase 4 clinical trial evaluating Antibiotics for UTI. Completed, enrolled 70 participants across 1 site.
Detailed Summary
To evaluate the feasibility of recruiting eligible subjects into a randomized trial of a culture-directed versus empiric antibiotic strategy for patient-reported urinary tract infection symptoms in older women and the adherence to study procedures.
Study Details
Timeline
Phase 4CompletedFinished
202420252026
First PostedFeb 2023
Enrollment StartFeb 2023
Primary CompletionAug 2024
TodayJul 2026
First PostedFeb 13, 2023
Enrollment StartFeb 17, 2023
Primary CompletionAug 2, 2024
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 3.4 years ago
Interventions
Antibioticsdrug
Participants will be provided either nitrofurantoin 100 mg oral twice a day for 5 days, trimethoprim/sulfamethoxazole 875/125 oral twice a day for 3 days, fosfomycin 3g once oral, ciprofloxacin 250 mg oral twice a day for 5 days or cephalexin 500 mg oral twice a day for 5 days